Status:
TERMINATED
Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis
Lead Sponsor:
Sheba Medical Center
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
5-40 years
Phase:
NA
Brief Summary
Patients with Cystic Fibrosis have multiple pulmonary infections and repeated antibiotic treatment. These factors taken together with high sputum viscosity and slow motility of the gastrointestinal tr...
Detailed Description
Patients with Cystic Fibrosis have multiple pulmonary infections and repeated antibiotic treatment. These factors taken together with high sputum viscosity and slow motility of the gastrointestinal tr...
Eligibility Criteria
Inclusion
- cystic fibrosis mild to moderate
- at least 3 pulmonary exacerbations requiring antibiotics per year
- Pseudomonas aeruginosa in the sputum
- able to produce sputum
Exclusion
- severe pulmonary disease
- less than 3 pulmonary exacerbations per year
- unable to produce sputum
Key Trial Info
Start Date :
October 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01201434
Start Date
October 1 2010
End Date
December 1 2013
Last Update
July 22 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.